1. Home
  2. SNCR vs CMRX Comparison

SNCR vs CMRX Comparison

Compare SNCR & CMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNCR
  • CMRX
  • Stock Information
  • Founded
  • SNCR 2000
  • CMRX 2000
  • Country
  • SNCR United States
  • CMRX United States
  • Employees
  • SNCR N/A
  • CMRX N/A
  • Industry
  • SNCR EDP Services
  • CMRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SNCR Technology
  • CMRX Health Care
  • Exchange
  • SNCR Nasdaq
  • CMRX Nasdaq
  • Market Cap
  • SNCR 137.5M
  • CMRX 77.0M
  • IPO Year
  • SNCR 2006
  • CMRX 2013
  • Fundamental
  • Price
  • SNCR $11.25
  • CMRX $0.93
  • Analyst Decision
  • SNCR
  • CMRX Strong Buy
  • Analyst Count
  • SNCR 0
  • CMRX 1
  • Target Price
  • SNCR N/A
  • CMRX $11.00
  • AVG Volume (30 Days)
  • SNCR 81.2K
  • CMRX 119.4K
  • Earning Date
  • SNCR 11-12-2024
  • CMRX 11-08-2024
  • Dividend Yield
  • SNCR N/A
  • CMRX N/A
  • EPS Growth
  • SNCR N/A
  • CMRX N/A
  • EPS
  • SNCR N/A
  • CMRX N/A
  • Revenue
  • SNCR $167,615,000.00
  • CMRX $144,000.00
  • Revenue This Year
  • SNCR $7.76
  • CMRX $3,040.12
  • Revenue Next Year
  • SNCR $5.83
  • CMRX N/A
  • P/E Ratio
  • SNCR N/A
  • CMRX N/A
  • Revenue Growth
  • SNCR 33.39
  • CMRX N/A
  • 52 Week Low
  • SNCR $2.70
  • CMRX $0.75
  • 52 Week High
  • SNCR $15.46
  • CMRX $1.30
  • Technical
  • Relative Strength Index (RSI)
  • SNCR 43.11
  • CMRX 60.78
  • Support Level
  • SNCR $10.45
  • CMRX $0.80
  • Resistance Level
  • SNCR $11.44
  • CMRX $0.98
  • Average True Range (ATR)
  • SNCR 0.57
  • CMRX 0.05
  • MACD
  • SNCR -0.06
  • CMRX 0.01
  • Stochastic Oscillator
  • SNCR 31.58
  • CMRX 83.33

About SNCR Synchronoss Technologies Inc.

Synchronoss Technologies Inc is a leading provider of white-label cloud, messaging, digital and network management solutions that enable its customers to keep subscribers, systems, networks and content in sync. The Synchronoss Personal CloudTM solution is designed to create an engaging and trusted customer experience through ongoing content management and engagement. The Synchronoss Personal CloudTM platform is a secure and highly scalable, white-label platform that allows its customers' subscribers to backup and protect, engage with, and manage their personal content. The company derives revenue from subscriptions and transaction-based fees. A majority of the firm's revenue is generated in the United States, and the rest is from countries across the world.

About CMRX Chimerix Inc.

Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals.

Share on Social Networks: